Search | IOVS | ARVO Journals

View

Showing 1 – 13 of 13

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2017

Clinical features and a novel CHM mutation in a Portuguese family with X-linked choroideremia

Liliana P Paris; Márcia Rodrigues; Luísa Coutinho-Santos

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1489. doi:

ARVO Annual Meeting Abstract September 2016

β-catenin in retinal interneurons is important for maintaining stability of the retinal microvasculature

Yoshihiko Usui; Peter D Westenskow; Toshihide Kurihara; Edith Aguilar; Liliana P Paris; Susumu Sakimoto; Salome Murinello; Felicitas Bucher; Daniel Feitelberg; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2762. doi:

ARVO Annual Meeting Abstract September 2016

Reducing retinal oxidative metabolism to arrest progression of ischemic retinopathies

Liliana P Paris; Marin L Gantner; Peter D Westenskow; Tim U Krohne; Edith Aguilar; Yoshihiko Usui; Jennifer K Trombley; Daniel Feitelberg; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):103. doi:

ARVO Annual Meeting Abstract June 2015

Human iPSC-derived retinal pigment epithelium allografts are stable for over two years and do not elicit detrimental effects in rats

Daniel Feitelberg; Peter D Westenskow; Stephen Bravo; Toshihide Kurihara; Felicitas Bucher; Liliana P Paris; Edith Aguilar; Carli M Wittgrove; Jonathan H. Lin; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1838. doi:

ARVO Annual Meeting Abstract June 2015

Neurovascular crosstalk between retinal interneurons and intraretinal capillaries is required for murine visual function

Yoshihiko Usui; Peter D Westenskow; Toshihide Kurihara; Edith Aguilar; Susumu Sakimoto; Liliana P Paris; Carli M Wittgrove; Daniel Feitelberg; Stacey K Moreno; Martin Friedlander; No

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3234. doi:

ARVO Annual Meeting Abstract June 2015

Prominent arginine-proline metabolic pathway perturbations characterize human proliferative diabetic retinopathy and the oxygen-induced-retinopathy mouse model

Liliana P Paris; Caroline H. Johnson; Edith Aguilar; Daniel Feitelberg; Yoshihiko Usui; Kinya Tsubota; Shunichiro Ueda; Yoshihiro Wakabayashi; Gary Siuzdak; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5203. doi:

ARVO Annual Meeting Abstract April 2014

Induced Pluripotent Stem Cell-derived Tissues Elicit Selective Immunogenicity

Daniel Feitelberg; Peter D Westenskow; Stephen Bravo; Tongbiao Zhao; Zhili Rong; Carli M Wittgrove; Liliana P Paris; Dennis O Clegg; Yang Xu; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2673. doi:

ARVO Annual Meeting Abstract April 2014

Amacrine cell-derived VEGF is required for development and maintenance of the retinal vasculature in mice

Yoshihiko Usui; Toshihide Kurihara; Peter D Westenskow; Edith Aguilar; Liliana P Paris; Stacey K Moreno; Carli M Wittgrove; Daniel Feitelberg; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3015. doi:

ARVO Annual Meeting Abstract April 2014

Angiogenin is a potent modulator of neovascularization and inflammation that is upregulated in various human retinal diseases

Carli M Wittgrove; Liliana P Paris; Yoshihiko Usui; Yoshihiro Wakabayashi; Edith Aguilar; Daniel Feitelberg; Peter D Westenskow; Leah C Byrne; John Gerard Flannery; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2242. doi:

ARVO Annual Meeting Abstract April 2014

Identification of a metabolite that can prevent features associated with proliferative diabetic retinopathy

Liliana P Paris; Caroline H Johnson; Peter D Westenskow; Yoshihiko Usui; Edith Aguilar; Daniel Feitelberg; Kinya Tsubota; Shunichiro Ueda; Gary Siuzdak; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4926. doi:

ARVO Annual Meeting Abstract June 2013

M-CSF Inhibition Prevents the Formation of Outer Retinal Neovascularization in a Murine Model of Macular Telangiectasia

Edith Aguilar; Toshihide Kurihara; Peter Westenskow; Stephen Bravo; Carli Wittgrove; Liliana Paris; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3847. doi:

ARVO Annual Meeting Abstract June 2013

RPE-specific VEGF Deletion Induces Geographic Atrophy: a Long-term Study

Liliana Paris; Toshihide Kurihara; Peter Westenskow; Stephen Bravo; Carli Wittgrove; Edith Aguilar; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):365. doi:

ARVO Annual Meeting Abstract June 2013

iPS-RPE implantation in the Royal College of Surgeons Rat does not lead to adverse events in a long term study of health and graft stability

Stephen Bravo; Peter Westenskow; Toshihide Kurihara; Alison Dorsey; Liliana Paris; Jonathan Lin; Martin Friedlander

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5811. doi:

Advertisement